X-CELLENT NATRILIX SR VERSUS CANDESARTAN AND AMLODIPINE IN THE REDUCTION OF SYSTOLIC BLOOD PRESSURE IN HYPERTENSIVE PATIENTS

Details for Australian Trade Mark No. 1033369 (hide)

Owner Biofarma

Service Refer to WIPO Address for Correspondence

Classes

Class 5 Pharmaceutical preparations for human use

Class 42 Scientific research services for medical purposes, namely clinical studies in the field of hypertension

Class 44 Consulting in the field of pharmacy; pharmaceutical or medical information services

Event Publications

18 May 2006 Application Lapsed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1033370-PRONIVIS

1033368-POLSA